The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed ...

The potential of monoclonal antibodies (mAbs) as therapies is indisputable. The current mAbs market is expected to be around ~USD 150 billion. In 2021, five out of the top 10 selling drugs were ...

Most shoppers are familiar with CVS Health’s many private label products, from women’s daily multivitamins to heart-healthy trail mix. There is a reason CVS and other retailers place those ...

MSD’s monoclonal antibody, indicated for 15 types of cancer, smashed industry records with sales of $27.3 billion in 2024, ...

A BLA has been filed for bentracimab and, if approved, has the potential to be the first therapy to reverse the effects of ...

“Bacteria just grow,” says Rodrigo Ribeiro, molecular biologist and regional marketing manager at Eppendorf North America. “I used to work with E. coli for protein expression, but when you ...

Alpana Mohta, MD, is a dual board-certified dermatologist, venereologist, and leprologist, with a research focus on immunotherapy for viral diseases and autoimmune disorders. With over 80 publications ...

An antibody discovery platform revealed more than 60 monoclonal antibodies specific to patients with alpha-gal syndrome, ...

The Food and Drug Administration has approved more than 100 monoclonal antibodies to treat a range of diseases. Other antibodies are used by physicians to diagnose conditions or by scientists to ...